A majority of patients using GLP-1 injections for weight loss have successfully maintained their weight by spacing out their doses from weekly to every two or three weeks.
A recent report from Brazil highlights a growing trend among patients using GLP-1 weight-loss injections, commonly known as 'weight-loss pens.' Many patients have opted to space their injections from once a week to once every two or three weeks, and evidence suggests this strategy is effective in maintaining weight loss. Dr. Mitch Biermann, an obesity specialist at Scripps Clinic in San Diego, noted that multiple patients reported success with this altered approach, prompting him to recommend it to others.
In a study designed to further investigate this method, results indicated that the majority of participants who reduced the frequency of their GLP-1 injections were able to sustain their weight loss over a span of 36 weeks. Not only did they maintain their weight, but they also experienced significant health benefits, including lowered blood pressure and improved blood sugar control. This finding could have implications for weight management strategies employing GLP-1 medications.
The implications of these findings are noteworthy; they suggest that rigid weekly schedules for medication can be adjusted without sacrificing effectiveness. For patients who struggle with the lifestyle changes necessary for sustained weight loss, this flexibility might improve adherence to treatment regimens and overall long-term health outcomes. These insights could pave the way for new clinical guidelines in the use of GLP-1 medications for obesity treatment.
